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Abstract
Mental health in the United States is at an all-time low with 21% of adults 18+ suffering
from depression or anxiety. When compared with other categories, emerging adults (18-25 years
old) have the highest prevalence of mental health disorders at 30%. Young adults face an
inordinate amount of stress given the COVID-19 pandemic, being in a unique developmental
stage, experiencing new relationships, and transitioning from high school to their professional
lives. Vitamins and minerals have roles in neurobiochemistry and have been investigated for
effects on mental health with mixed results. Few studies factor in the unique emerging adult
developmental stage or the potential influence of excessive body weight, which is associated
with poor psychosocial measures. The purpose of this project is to investigate whether
multivitamin-mineral (MVM) supplementation lowers measures of negative psychosocial
functioning. To explore this, a randomized, placebo-controlled trial was done to compare the
effects of MVM supplementation on mental health measures to those with no supplementation.
One hundred and thirty-six young adults recruited by body mass index (BMI) completed the
study after being randomly assigned to take a MVM supplement or placebo for 30 days.
Participants completed the Beck Anxiety Inventory (BAI), the Center for Epidemiologic Studies
Depression Scale (CES-D), the Single Item for Self-Esteem (SISE), the Abbreviated
Dysregulation Inventory (ADI), and the Perceived Stress Scale (PSS) at baseline and again at the
completion of the study. Data was analyzed using Independent Samples T-Test of change scores
to determine if MVM supplementation improved psychological function in young adults
compared with placebo, and whether the effect was more likely in those with overweight/obese
BMI. Mean change score for the BAI (anxiety) was 5.42 (SD = 8.05) for the MVM group versus
2.05 (SD=6.79) for the placebo group, indicating that the MVM improved scores more so than

placebo (P = 0.003). MVM supplementation did not have an effect on measures of depression,
dysregulation, self-esteem, or perceived stress. Likewise, there was no difference in response
based on BMI. MVM supplementation may be a simple, practical, and cost-effective strategy to
lower symptoms of anxiety in young adults.
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Introduction
Mental health issues like depression and anxiety are common in the United States with
approximately 1 in 5 adults 18 and older suffering from an array of mental health problems [1].
These disorders lend to higher perceived stress, lower self-esteem, dysregulation, and an overall
diminished quality of life [2]. Micronutrients are vitamins and minerals needed by all people in
relatively small amounts, and are vital to normal development. They support the body in carrying
out biological processes and contribute to overall well-being. Also, low biochemical levels of
micronutrients are associated with poor cognitive function and mood [3]. This may be due to the
various physical conditions and ailments that can develop without proper micronutrition which
can drastically affect feelings of well-being. Even mild micronutrient deficiencies can result in a
reduced feeling of well-being, overall fatigue, impaired memory, and reduced mood as the body
does not have the building blocks for optimal functioning [4]. Aside from Vitamin D, the body
cannot produce vitamins and minerals endogenously, so they must come from the diet. To
support optimal health, many governments have developed recommended intakes of each
micronutrient, but even with this guidance, many people are not meeting the minimum levels.
The World Health Organization (WHO) estimates that over 2 billion people suffer from
micronutrient deficiencies worldwide [5].
A group that is at risk of deficiency includes young adults (age 18-25), especially those
that are overweight/obese [6]. Young adults are in a distinct developmental period referred to as
emerging adulthood, however in research studies they are most often grouped with all adults
despite being in a distinct developmental period and having very different challenges and
lifestyles. Overweight/obesity adds an extra layer of complexity as this group is more likely to
have a deficient micronutrient status [7].
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The primary aim of the present study was to evaluate whether multivitamin-mineral
(MVM) supplementation would improve symptoms of anxiety, depression, perceived stress,
dysregulation, and low self-esteem in young adults. In addition, these measures were compared
between normal weight and overweight/obese individuals to determine if weight had an effect on
psychological outcomes.

Review of Literature
Mental Health in the United States
The United States is facing a national mental health crisis [8]. Twenty one percent of the
US adult population, or 1 out of every 5 adults, live with a mental health disorder like depression
or anxiety [1]. Symptoms of anxiety and depression and related challenges of low self-esteem,
emotional dysregulation, and perceived stress are connected with higher productivity loss and
more trouble in relationships [9,10]. Action should be taken to lower the strain of mental illness.
Accessible, cost-effective solutions need to be proposed so that Americans can feel better and
experience psychological well-being.

Micronutrients
Several vitamins and minerals are thought to contribute to psychological well-being.
Some vitamins have been specifically identified for their contribution to brain and mental
health. B-vitamins, which include Vitamin B12, B6, thiamin (B1), riboflavin (B2), niacin (B3),
pantothenic acid (B5), biotin (B7), and folate (B9) are important in energy metabolism and a
lack can slow energy and affect psychological measures [11]. A deficiency of these vitamins has
been linked to neurotoxic levels of the amino acid homocysteine, the accumulation of which can
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affect mood [12]. B-vitamins supplementation can decrease homocysteine levels, which has the
potential to alleviate symptoms of depression and other mood related measures [13,14].
Vitamin C is another vitamin of interest, as moderate deficiencies can decrease dopamine
levels, resulting in symptoms like depression, anxiety, fatigue, irritability, and mood changes
[15]. Vitamin C and other antioxidant vitamins (A and E) can also offer protection against
oxidative stress. Oxidative stress is caused when there are more free radicals than antioxidants
in the body. Antioxidants have the ability to neutralize free radicals. When there are more free
radicals than available antioxidants, brain functioning and neuronal signaling are negatively
affected, creating pathways for depression and anxiety. Antioxidant supplementation can
neutralize oxidative stress, thus having the potential to reduce levels of depression and anxiety
[16].
Minerals such as selenium, zinc, calcium, and magnesium have been tied to improving
psychological states. Selenium has been shown to improve symptoms of depression and anxiety
[13]. Zinc is an important mineral in immunity and wound healing, the lack of which has been
connected to depression [17]. Magnesium is an essential mineral in nerve transmission and
neuromuscular conduction. Data strongly supports its use in alleviating symptoms of depression
and emerging data suggests it may have a protective effect on anxiety [18].
Because nutrients do not function in isolation, it is important to consider the benefits of a
multivitamin-mineral supplement rather than just an isolated vitamin or mineral. Those with a
deficiency in one vitamin or mineral are likely deficient in others as well and could benefit from
a well-rounded supplement.
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Micronutrient Supplementation and Effects on Anxiety and Depression
Several randomized placebo-controlled trials have shown promising results in MVM
supplements and their effects on anxiety. In a 28-day study with 80 men who were given either a
MVM supplement or placebo, there was a reduction in symptoms of anxiety [17]. In another
study with 300 men and women aged 20-50, significant improvements in anxiety were evident
after 30 days of treatment [19]. In a meta-analysis, 2 out of 4 studies showed decreased anxiety
measures in subjects who took MVM supplements. When pooling all the participants across the
studies, the summated effect showed an improvement in subclinical measures of anxiety [13]. In
another study of 65 men and women (45-64 years old) following a gluten-free dietary pattern,
those with higher scores of anxiety and depression at baseline had lower scores after 6 months of
MVM supplementation [20].
Similar positive results were seen in studies focusing on depression outcomes. In a study
of 60 people receiving either a MVM supplement or placebo for 12 weeks, there was a reduction
in depressed/dejected mood [21]. Another study of 114 healthy college students reported that,
after 6 months of MVM supplementation, they responded with reduced symptoms of depression
[11]. However, the placebo group also reported reduced symptoms as well, likely attributed to
response expectancy.
While there is evidence of improvement in depression and anxiety by taking MVM
supplements, there are also studies that show no effect. An 8-week trial with 50 women aged 2545 showed no improvement in psychological state after a MVM treatment [22]. A meta-analysis
of 3 trials focusing on MVM supplementation and depression reported no effect when pooling
the data together [13]. In another meta-analysis of 9 different studies on depression outcomes,
none showed any benefit [23]. In a systematic review on anxiety outcomes, 6 out of 10 studies
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showed no benefits. Of the positive studies, two showed an overall reduction in anxiety, while
one showed positive results in a subgroup of participants with poor anxiety status at baseline and
another only showed positive results in males [23].

Micronutrient Supplementation and Effects on Perceived Stress, Dysregulation, and Self-Esteem
Perhaps the most promising benefit from MVM supplementation is its effect on perceived
stress. A number of studies have shown decreased stress ratings following a period of
supplementation with multivitamin-minerals. In a 28-day study of 80 men, there was a
reduction in perceived stress [17]. A 33-day study of 215 men aged 30-55 also reported
improvement in perceived stress scores [24]. In a trial with older men aged 50-69, participants
lowered their stress after 8 weeks of receiving supplementation [25]. In a trial with 173 younger
men with a mean age of 20.9 years old, perceived stress was lowered after 12 weeks on a MVM
supplement [26]. A study of 59 18–65-year-olds showed an improvement in symptoms of
perceived stress after 12 weeks [27]. Another longer study with 108 people ranging in ages from
30-70 showed a reduction in perceived stress after 6 months. Interestingly, the placebo group
also showed a reduction in perceived stress, demonstrating the influence of the placebo effect
[28].
While the literature suggests regular multivitamin-mineral supplementation has positive
effects on reducing perceived stress, it is worth noting that not all studies showed benefits. In a
systematic review, 4 out of 10 studies did not show any decrease in perceived stress after
supplementation [23]. In a meta-analysis, 3 of 8 studies also did not report a reduction in stress
[13]. Heterogeneity across studies including different MVM formulations, populations, and
methodologies can contribute to the differing results.
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To my knowledge, there are no published studies of MVM supplementation and its effect
on dysregulation or self-esteem. However, dysregulation and low self-esteem are closely tied to
anxiety and depression, which have been studied [2]. Dysregulation refers to the poor ability to
manage emotional responses. In dysregulated people, emotions are overly intense in comparison
to the situation that triggered them. The result is impulsive, out of control behavior. Self-esteem
is the judgement that individuals make about their own self-worth. Low self-esteem is a
precursor to depression in young adults and is a risk factor for depressive symptoms throughout
all stages of adult life [29]. Because even small micronutrient deficiencies can alter brain
biochemistry, mood changes can result from unbalanced diets. It stands to reason that balancing
biochemical levels in the brain can regulate mood, emotions, and improve self-esteem.

Limitations to Existing Research
Although there is some evidence suggesting micronutrient supplementation may be a
means to decrease risk of anxiety, depression, dysregulation, low self-esteem, and perceived
stress, there are key limitations in how most of the studies were designed. These limitations
include not factoring in the unique developmental stage of emerging adulthood, the potential
influencing effect of excess body weight, and the use of supplements that contain constituents
other than vitamins and minerals. Those in the developmental stage of emerging adulthood
and/or having excess body weight may be at higher risk for symptoms of psychological issues
as discussed in detail below. The use of a supplement that includes non-nutrient constituents as
a study treatment hinders the ability to study the effects specific to vitamins and minerals as also
discussed in detail below.
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Influence of Emerging Adulthood. Young adulthood (age 18-25) is a unique and often
overlooked developmental period. It is a transitionary period bridging life as a teenager to one of
independence, making major life decisions, and beginning their professional careers [30]. Their
life stage and experience present specific challenges on both their physical and emotional health.
Young adults must learn to manage finances, with limited life and work experience. If in college,
they manage frequent deadlines, pressures of testing and making good grades, while balancing a
social life. This time of life is characterized by change and exploration of possible life directions
[30]. Rates of anxiety and depression among young adults have always been higher than other
age categories, but they have skyrocketed during the Covid-19 pandemic [2]. Adding to regular
hardships are the added side effects of the pandemic: loneliness, job insecurity, social distancing,
cancelled events, and changing regulations. Data from a June 2020 CDC survey reported that
63% of young adults identify with an anxiety or depressive disorder. On top of that, a staggering
1 in 4 admitted to seriously considering suicide in the past 30 days [2]. Compared with other age
groups, young adults have the highest levels of perceived stress [8]. On average, young adults
rate their stress in the last month as 6.1 out of 10, compared with other groups who rate it as
5.6/10 (24–41-years old), 5.2/10 (42–55-years old), 4/10 (56–74-years old), and 3.3/10 (ages
75+). With a large proportion of young adults being college students, almost all of them (87%)
report education as a significant source of stress. Moreover, 82% feel stressed and uncertain
about what the year will look like, and 67% feel that planning for their future is impossible.
Depression is affecting large majorities of young adults with about 7 in 10 reporting they feel
restless, find it hard to think properly or concentrate, feel lonely, or miserable and unhappy.
Given such heavy pressures and mood disturbances, young adults need added resources
to cope. They are known for eating rushed meals, having sporadic eating patterns, and
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unhealthy food choices [4]. Excess alcohol and/or caffeine consumption can take the place of
nutrient dense food and also decrease micronutrient absorption [31]. Financial and time
restraints can prevent access to healthy, well-balanced meals. High stress, anxiety, and
depression can trigger high-sugar/high-fat cravings with little to no nutritive value [32]. These
feelings combined with societal pressure to be thin breed eating disorders like anorexia and
bulimia, which are common in this age group [33].

Influence on Overweight/Obesity. Overweight is defined by the World Health
Organization as having a body mass index (BMI) between 25-30 kg/m2 and obese as over 30
kg/m2. The prevalence of overweight/obesity in America is growing rapidly. In 1962, 13.4% of
the adult population in the United States was obese with 31.5% being overweight. Contrast that
with the latest numbers in 2018, 42.5% of American adults were obese with 73.6% being
overweight [34]. Aside from increased mortality, obesity increases the risk for diseases like
diabetes, cardiovascular disease, hypertension, and sleep apnea. There are also many
psychological effects. Overweight/obesity is associated with higher rates and risks of developing
anxiety and depression [35,36]. People with higher BMIs more often battle social stigmatization,
body image issues, and related self-esteem issues. In many cases obese people struggle with
binge eating that contributes to excess psychological stress [37].
Whether or not the micronutrient deficiencies contribute to the obesity or the obesity
causes the deficiencies is under debate [38]. Overweight/obese persons may be deficient in
vitamins/minerals because of their diet, which is typically low in fruits and vegetables [39].
Deficiencies can also be caused by a change in the way micronutrients are metabolized and
stored in adipose tissue [7]. Several studies show that the concentrations of serum antioxidants
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are inversely related to BMI; as BMI increases, antioxidant levels decrease. This could be the
result of the body spending more antioxidants to combat the higher oxidative stress found in
overweight/obese individuals [6]. A lack of B-vitamins can cause a buildup of homocysteine,
which has been linked to depression [12]. B-vitamins can improve symptoms of depression and
perceived stress by lowering homocysteine levels [13]. Homocysteine levels have been shown to
be significantly elevated in obese subjects [40]. Besides potential B-vitamin deficiencies,
overweight/obese people are at higher risk for many micronutrient deficiencies in comparison
with those of normal weight [41].

Influence of Supplement Composition. A third major limitation in comparing studies of
MVM supplementation is the differing composition of supplements. Many studies included
supplements that contained caffeine or herbal extracts, which have the potential to confound the
results. For example, caffeine is a well-known stimulant. St John’s wort is a popular herbal
remedy in several European countries with some evidence of efficacy for improving mild to
moderate depression [42]. At least 110 additional medicinal plants are under investigation for
anti-depressive effects [43]. Many MVM supplements studied for effects on psychological
measures included herbal/medicinal plant extracts along with the vitamins and minerals, making
it less clear whether any potential effect was from the herb or the micronutrient combination.
Also, different supplements with varying amounts of vitamins and minerals were used across
studies, thus making it difficult to generalize the results. Of note, J. Harris et al. said the current
formulation of the Berocca supplement is “the most widely studied multivitamin/mineral to date,
with the evidence suggesting beneficial effects on cognitive performance and potential increase
in physical energy levels” [3]. However, this particular supplement was only used in a handful of
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studies. Questions to ask when considering which supplement to use may include: What are the
active ingredients in the supplement? What is the optimal dose? Does baseline micronutrient
status contribute to the efficacy of the supplementation? Do different individuals need different
formulations?

Summary and Objectives
Micronutrients are vital to both physical and mental health. MVM supplements can cover
gaps in diet and nutrition to prevent deficiencies and ensure adequate health. There is ample
evidence supporting high B-vitamin MVM supplementation improving measures of perceived
stress. There is some evidence to support MVM supplementation to lessen symptoms of
depression and anxiety. The mixed results may be due to differences in the experimental
protocols, including different tests to measure outcomes, supplements with varying formulations,
and different length and timing of supplementation. There is no published data on MVM
supplementation and dysregulation or self-esteem, despite their close connection to anxiety and
depression.
While several studies discuss the benefits of MVM supplementation on mood measures, most
include a broader age range than 18-25. This younger group may be at higher risk for
micronutrient deficiencies and due to their higher levels of stress, anxiety, depression, and
psychological distress, may benefit more from supplementation. They are also at an opportune
time to enact behavioral changes to increase life-long health and vitality. A subgroup at even
more nutritional risk within the category of young adults are those who are overweight/obese.
MVM supplementation is a low-cost intervention and may be a simple way to bridge
micronutrient deficiencies and improve negative mood markers.
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To address the above limitations, the current study proposes to address young adults aged 1825. Young adults are at a stage of life where they have the ability to make choices and create
habits that will affect them lifelong. We will use a MVM supplement without added caffeine or
herbal extracts that is modeled after the Bayer produced, Berroca supplement, which has had
positive results in several studies [17,24,44]. It is formulated with higher B vitamins, vitamin C,
calcium, magnesium, and zinc. We will determine treatment effects over 30 days based on what
has been done in other studies with positive results [17,19,24]. We will assess the efficacy of this
supplement on measures of depression, anxiety, perceived stress, dysregulation, and low selfesteem in young adults. We will also compare whether there is a difference in effects between
those with normal BMI and those with overweight/obese BMI. We hypothesize that, after 30
days on the MVM supplement, mood measures will be improved and the effect will be greater in
overweight/obese participants.

Methods
Recruitment/Participants
A total of 136 young adults were recruited from a mid-south public university via flyers
on campus, postings in a campus newsletter, and through classroom announcements. To be
eligible, participants had to be 18-25 years old, going to school or working part-time; and have
no diagnosis of malabsorption or related gastrointestinal diagnoses, nor diagnosis of impaired
liver or renal function, nor any mental health diagnoses. They also had to agree to abstain from
other supplements during the study. All current supplementation was required to be suspended a
week prior to starting the study until after the study was completed. Potential participants were
screened on the phone by the study staff who followed scripted prompts to determine eligibility.
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Those who qualified were confirmed by learning the details about the study and completing the
informed consent process. Once confirmed, the study staff collected information on age, BMI,
health indicators, and nutritional status. A total of 136 people were randomized via a random
sequence generator and completed the study. This study was approved by the University of
Arkansas Institutional Review Board for human subject research (Approval #1709073942).

Randomization and Study Design
For this double-blinded study, participants were randomized using a random sequence
generator into two groups. The treatment group took two multivitamin-mineral supplements
daily for 30 days. The control group also took two capsules that were placebos with the exact
size, texture, and look of the multivitamins. The participants were assessed at the beginning and
end of the experiment (Day 0 and Day 30 respectively) via self-administered online
questionnaires. The MVM supplement was made specifically for the study by a Collier
Compounding Pharmacy, a local compounding pharmacy. The composition of the multivitaminmineral supplement was matched to the composition of Berroca tablets because the most
promising results published in the literature were studies that used this product [3]. They also did
not contain herbal extracts or caffeine which could have had their own effects on the endpoints
measured. The composition of the MVM supplement is detailed in Table 1.
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Table 1. Composition of MVM supplement
Vitamin/Mineral
B1 = Thiamin
B2 = Riboflavin
B3 = Nicotinamide
B5 = Pantothenic Acid
B6
B12
C
H = Biotin
Folic Acid
Calcium
Magnesium
Zinc

Amount in
Supplement
15 mg
15 mg
50 mg
23 mg
10 mg
10 µg
500 mg
150 µg
400 µg
100 mg
100 mg
10 mg

RDA

%RDA

1.1 – 1.2 mg
1.1 – 1.3 mg
14 – 16 mg
5 mg
1.3 mg
2.4 µg
75 – 90 µg
30 µg
400 µg
1,000 mg
310 – 400 mg
8 – 11 mg

1364
1364
357
460
769
416
667
500
100
10
32
125

Participants were given a week’s worth of supplements and then reported back to the
study office each week to return unused pills and receive pills for the upcoming week.
Compensation was also given during this check-in for each week completed. Compliance was
determined by measuring the unused pills that were returned to the office. Reminders were sent
out before pill pick up, to start supplementation, and to complete surveys. Subjects who
completed the entire study received $100 distributed incrementally throughout the 30 days as a
way to motivate continued compliance.

Questionnaires
Participants filled out an online survey at baseline and Day 30 of the study. The survey
was a combination of the following six randomly presented validated assessments that were
compiled as a single Qualtrics survey to measure psychological functioning. The Beck Anxiety
Inventory (BAI) is a 21-item survey that measures symptoms of anxiety on a Likert scale. A
score between 0-7 indicates minimal anxiety, 8-15 mild, 16-25 moderate, and 26-63 severe
anxiety. [45]. The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-
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reported measure of characteristic attitudes and symptoms of depression developed by the
National Institute of Mental Health. Scores over 16 indicate depression with higher scores
indicating more depression symptomology [46]. The Single Item for Self Esteem (SISE) is a
single item question that asks participants to rate their self-esteem on a Likert scale. It is a
validated test shown to be as reliable as the Rosenberg Self-Esteem Scale [47]. The Abbreviated
Dysregulation Inventory (ADI) is a shortened version of the more complete Psychological
Dysregulation Inventory. It is a 30-item survey that assesses emotional, cognitive, and behavioral
dysregulation [48]. The Perceived Stress Scale (PSS) is the most widely used instrument for
measuring the perception of stress with only 10 questions [49]. Subjects were reminded via text
and email to complete the assessments within 3 hours of taking the supplement.

Body Mass Index (BMI)
Each subject was weighed and measured by trained study staff to get an accurate BMI on
day 0 and day 30. Participants were asked to remove their shoes and anything heavy to obtain the
most accurate measurements. Height was measured in centimeters using a stadiometer and
converted to meters to be calculated. Weight was taken in kilometers by a portable scale. BMI
was then computed online with a BMI calculator [50]. Subject’s BMI placed them in a normal
weight or overweight/obese group. After all data was collected, a two tailed independent samples
t-test was performed on the change scores for each mood measure to test the hypothesis that
those with overweight/obese BMIs would see a greater improvement in psychological
functioning with MVM supplementation.
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Statistical Analyses
First, descriptive statistics were conducted on the full sample. Dependent variables
included anxiety, depression, perceived stress, dysregulation, and self-esteem. Higher scores
indicated higher anxiety, depression, perceived stress, dysregulation, and lower self-esteem.
Next, a change score was calculated for each of the dependent variables by taking the 30-day
scores and subtracting them from corresponding baseline scores. An independent t-test was run
to detect both main effects as well as interaction effects between the control and intervention
group. Further analysis was conducted using change scores and an independent two-tailed t-test
for both normal and overweight/obese BMI groups. Because the hypothesis was based on change
in only one direction, the two tailed p-value was divided in half and the new p-value <0.05 was
considered significant. Levene’s test for equality of variances was run on all variables to
determine if equal variances could be assumed or not. Effect size was measured by Cohen’s d to
see the relationship between the variables with d=0.8 representing a large effect size, d=0.5 a
medium effect size, and d=0.2 a small effect size. Analyses were conducted using SPSS, v. 27
[51].

Results
Participant Characteristics
The study had a total of 154 participants at baseline. After accounting for non-compliance
and dropouts, 136 participants were included for data analysis. Of the 136 participants, 63
received placebo and 73 received the MVM supplement (Table 2). The majority of participants
were students, living in an urban area, and employed part-time. The study was made up of 108
females (47 received placebo and 61 received the supplement) and 28 males (16 received
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placebo and 12 received the supplement). Student status was similar between groups with the
exception of the placebo group having more juniors and the supplement group having more
seniors. There was no significant difference between groups in regards to BMI, age, geographic
living location, and employment status.
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Table 2. Participant characteristics and p-values for comparison of characteristics
between placebo and MVM groups.

Gender
Females
Males
BMI
Normal (18.5-24.9)
Overweight/obese (>25)
Age (Average ± SD)
Student Status
Non-Student
Freshman
Sophomore
Junior
Senior
Grad Student
Geographic living location
Rural
Urban
Level of Education
Completed
Some high school
High school
Some college
Associate degree
Bachelor’s degree
Post-graduate degree
Employment Status
Unemployed
Part-time
Full-time

Placebo
(N=63)

MVM
(N=73)

47 (74.6%)
16 (25.4%)

61 (83.6%)
12 (16.4%)

P-value of
differences
between
groups
0.103

0.363
33
30
20.89 ± 1.87

35
38
20.47 ± 1.68
0.436

2 (3.2%)
8 (12.7%)
13 (20.6%)
18 (28.6%)
13 (20.6%)
9 (14.3%)

1 (1.4%)
10 (13.7%)
19 (26%)
9 (12.3%)
25 (34.2%)
8 (11%)
0.140

5 (7.9%)
58 (92.1%)

10 (13.7%)
63 (86.3%)
0.050

0 (0%)
10 (15.9%)
37 (58.7%)
4 (6.3%)
11 (17.5%)
1 (1.6%)

1 (1.4%)
17 (23.3%)
44 (60.3%)
1 (1.4%)
10 (13.7%)
0 (0%)
0.417

20 (31.7%)
39 (61.9%)
4 (6.3%)

23 (31.5%)
44 (60.3%)
6 (8.2%)
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Change in Psychological Variables
Changes in psychological functioning were analyzed by treatment (placebo or
supplement) x time (baseline, post-treatment). Descriptive statistics are presented on mood
measures at baseline and 30 days in Table 3. Levene’s test for equality of variances passed on all
mood measures except for dysregulation so equal variances were not assumed with the ADI
change score. This gave a higher p-value for dysregulation. Analyses using an alpha level of 0.05
revealed statistically significant pre-post effects on measures of anxiety, indicating that MVM
supplementation reduced anxiety with moderate effect (t(134) =-2.82, p=0.003, d=-0.485).
Dysregulation measures also improved with a statistically significant change score, but in favor
of the placebo (t(103)=1.76, p=0.041, d=0.31). When comparing change scores for the
subcomponents of dysregulation (emotional, cognitive, and behavioral) there was a statistically
significant difference for cognitive dysregulation, but in favor of the placebo. There was no
improvement in perceived stress (t(134)=-0.034, p=0.49, d=-0.006). There was also no difference
between treatment and placebo groups on measures of depression (t(134)=1.58, p=0.058,
d=0.27) or self-esteem (t(134)=0.38, p=0.35, d=0.065).
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Table 3: Mean (+/- SD) scores of placebo and MVM for psychological measures at baseline and
30 days with change scores and p-value for comparison of change scores between placebo and
MVM groups.
Assessment

Beck Anxiety

Group

MVM

Sample
size
(N)
73

Inventory
Placebo
Abbreviated

MVM

63
73

Dysregulation

Baseline
mean
(SD)

Day 30
mean
(SD)

Change
score
mean
(SD)

29.78

24.36

5.42

(8.05)

(4.87)

(7.10)

27.76

25.71

2.05

(0.77)

(0.77)

(6.79)

63.07

60.07

3.00

(7.28)

(6.77)

(6.16)

61.87

56.40

5.48

(8.42)

(10.02)

(9.59)

18.62

16.90

1.73

(3.35)

(3.56)

(3.35)

19.05

16.37

2.68

(3.07)

(3.83)

(3.70)

2.22

2.05

0.16

(0.80)

(0.80)

(0.58)

2.25

2.05

0.21

(0.90)

(0.87)

(0.72)

20.90

20.07

0.84

(5.14)

(5.86)

(7.06)

21.19

20.40

0.79

(5.60)

(4.62)

(7.14)

P-value
of the
change
score
P=0.003

P=0.041

Inventory
Placebo
Center for

MVM

63
73

Epidemiologic

P=0.058

Studies
Depression
Scale
Placebo
Single Item

MVM

63
73

for Self-

P=0.35

Esteem
Placebo
Perceived

MVM

63
73

Stress Scale
Placebo

63

P=0.49
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Effect of BMI
We also determined whether MVM supplementation had a greater effect on measures of
psychological functioning in those with excess weight. There was a statistically significant
difference in change scores between the placebo and MVM group for depression, however it was
in favor of the placebo group (t(134)=1.99, p=0.025, d=0.341). No statistically significant effect
was found for dysregulation (t(134)=0.17, p=0.433, d=0.029), perceived stress (t(134)=-0.47,
p=0.319, d=-0.081), self-esteem (t(134)=-0.66, p=0.255, d=-0.114), or anxiety (t(134)=-0.66,
p=0.256, d=-0.113).
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Table 4: Mean (+/- SD) scores of normal and overweight BMI for psychological measures at
baseline and 30 days with change scores and p-values for comparisons of change scores between
overweight and normal BMI groups.
Assessment

BMI
Group

Beck Anxiety

Overweight

Sample
size
(N)
68

Inventory
Normal
Abbreviated

Overweight

68
68

Dysregulation

Baseline
mean
(SD)

Day 30
mean
(SD)

Change
score
mean
(SD)

28.74

25.28

3.46

(8.00)

(5.47)

(7.80)

28.96

24.69

4.26

(6.48)

(5.56)

(6.45)

62.90

58.63

4.26

(7.60)

(8.55)

(8.59)

62.13

58.10

4.03

(8.07)

(8.70)

(7.42)

18.88

16.12

2.76

(3.30)

(3.64)

(3.50)

18.75

17.18

1.57

(3.15)

(3.67)

(3.50)

2.07

1.93

0.15

(0.76)

(0.68)

(0.63)

2.40

2.18

0.22

(0.90)

(0.95)

(0.67)

20.88

20.35

0.53

(4.90)

(5.75)

(7.17)

21.19

20.09

1.10

(5.78)

(4.86)

(7.01)

P-value
of the
change
score
P=0.256

P=0.433

Inventory
Normal
Center for

Overweight

68
68

Epidemiologic

P=0.025

Studies
Depression
Scale
Normal
Single Item

Overweight

68
68

for Self-

P=0.255

Esteem
Normal
Perceived

Overweight

68
68

Stress Scale
Normal

68

P=0.319
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Discussion
Anxiety
Taking a MVM supplement for 30 days decreased anxiety in young adults in this study.
Previous studies on multivitamin-mineral supplementation and anxiety showed mixed results
with some studies reporting an effect [13,17,20] and others showing no difference [21,23]. Part
of the discrepancy in results may be due to heterogeneity between studies. For one, studies used
different formulations of multivitamins and minerals in their supplements. Our study used a
formulation that contained high B-vitamins that has been shown to have greater effect [13].
Sample sizes and target populations also varied widely from 50 older men [25] to 216 women
aged 25-50 [14]. No other study focused solely on young adults ages 18-25. Another reason for
the mixed results could be the difference in instruments used to measure anxiety. Out of 8
studies, ours is the only one that used the Beck Anxiety Inventory (BAI) [13]. Other inventories
used included the Hospital Anxiety and Depression Scale (HADS), the Hamilton Anxiety Rating
Scale (HAM-A), the Depression Anxiety Stress Scale (DASS), the General Health
Questionnaire-28 (GHQ-28), and the Visual Analog Scale (VAS). The BAI’s focus on somatic
symptomology allows it to better differentiate anxiety from depression. The other scales directly
(HADS) [52] or indirectly (HAM-A) [53] measure both anxiety and depression. Other scales also
additionally measure perceived stress (DASS) [54], insomnia, and social dysfunction (GHQ-28)
[55]. Another commonly used survey was the VAS, which measures subjective mood at the
present moment and not retroactively like the other Likert scales [25]. This method of testing
would primarily reveal acute effects of supplementation. However, studies with check-in
protocols that require an overnight fast and abstinence from MVM supplementation when testing
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would not benefit from the multivitamin-mineral’s acute effects [21] and that may be reflected
with the VAS.
Another key difference in our study is the number of females compared with the number
of males in prior research on anxiety and MVM supplementation. A large majority of previous
studies were conducted with male study participants [17,24,25,44] and our research had a large
percentage of females. Women tend to have overall more anxiety than males [56], thus MVM
supplementation could have a greater effect on them.
Differing methodology can potentially explain some of the negative results in other
studies. In one study of 216 females, both the MVM and placebo groups showed an increase in
anxiety after 62 days [14]. However, this study was primarily measuring cognitive function and
assessing anxiety was secondary. Participants went to a lab for several hours to perform memory
tasks, take mood surveys, and get their blood drawn. Wanting to perform well on tests they had
previously taken and in an anxiety-provoking environment could explain the increase in anxiety,
especially since it was shown in both groups. In another study of 60 men and women with a
mean age of 42.2 years old (SD 10.1 years), there was no difference in anxiety between groups
after 90 days of MVM supplementation. Besides having an overall small sample size, this study
also used two different MVM pills- one was a sustained release pill to allow for slower
absorption and the other was regular [21]. The inclusion of a sustained release pill could limit the
acute effect subjects may have felt when testing, thus altering the results. The population was
also very different- focusing primarily on people employed full-time who deal with chronic,
work stress.

23

Dysregulation and Self-Esteem
MVM supplementation also resulted in lowered levels of dysregulation in young adults
for both treatment and placebo groups. However, the placebo group had a lower score than the
MVM, indicating that the MVM did not perform better than the placebo. The Abbreviated
Dysregulation Inventory was used to measure 3 categories of dysregulation: emotional,
cognitive, and behavioral. In a study that investigated gender differences in cognitive,
behavioral, and affective dysregulation with 551 participants aged 12-19, male participants
presented higher scores in behavioral dysregulation than girls [57]. Because our study contained
a large majority of females, dysregulation results may have been skewed more than if a
traditional measure of dysregulation was used. Most available instruments to measure
dysregulation only focus on the emotional aspect of dysregulation. Another explanation for the
results includes the possibility that multivitamin-minerals do not have an effect on dysregulation.
In a comparative study on emotional dysregulation between 50 older adults (aged 60-80) and
young adults (aged 18-30), the older adults showed less emotion dysregulation suggesting an
improved ability with age to cope with emotions [58]. It is possible that young adults need time
and life experience to develop healthy self-regulation and it’s not something that can be
influenced biologically.
There was no difference in regards to self-esteem in young adults. Self-esteem scoring is
subjective and can easily change depending on mood. We hypothesized an effect from MVM
supplementation as the acute effects from supplementation have been shown to improve mood,
which could raise self-esteem ratings. A possible reason for our results could be the single-item
test used to measure self-esteem. While proven to be valid, it also has lower test-retest reliability
than multi-item measures of global self-esteem like the Rosenberg Self-Esteem scale. The SISE
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is more susceptible to extremity and agreement bias because it only has one positively keyed
item [59].
Although our study did not connect MVM supplementation with higher self-esteem, it is
still an area worth pursuing. Low self-esteem levels are linked with depression, suicidal ideation,
loneliness, peer rejection, poor academic performance, and life dissatisfaction [60]. Exploration
of supplement timing, length of treatment, and supplement formulation are appropriate subjects
for further research.

Perceived Stress and Depression
The lack of a difference between placebo and multivitamin groups on measures of
perceived stress did not align with previous research that showed a strong relationship. Several
methodological differences between the current study and the majority of previous studies
provide some reasons for the discrepancy in results. As mentioned with anxiety measures, the
majority of the previous research was done on men, while our study included 79% women. This
combined with the unique area of focus on young adults may also contribute to the differing
results. Women respond differently to stress than men and are more likely to experience stress in
the form of physical symptoms [61]. Moreover, young adults are the most likely group to suffer
with stress [2]. Our study contained one of the most stressed cohorts in America. Another major
methodological difference is that most of the prior research used supplements containing added
herbal extracts. Popular choices were ginkgo biloba and green tea [19,62]. Gingko biloba is a
plant extract that has been shown in multiple studies to lower rates of oxidative stress, which
contribute to many conditions like depression and anxiety [63]. Oxidative stress has been linked
to higher rates of perceived stress [64]. Green tea is made from Camellia sinensis leaves and has
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properties that can modulate EEG oscillatory brain activity, which is associated with relaxation
and perception of stress [65]. These additions may contribute to the improvements in perceived
stress more than vitamins and minerals on their own. Our study intentionally excluded herbal
extracts and caffeine to better isolate the potential effects of the vitamins and minerals.
Another difference in results may be due to the inventories used to measure perceived
stress. In a study of working adults, one of the primary measures of perceived stress was the
Occupational Stress Inventory-Revised (OSI-R) [21]. It specifically measures work-related
functioning and stress. Our population was primarily college students, who experience stress, but
perhaps in a different way.
Many of the studies showing improvement of perceived stress after MVM treatment
include biochemical analysis at pre and post testing to measure compliance and stress biomarkers
[17,27,28]. In a study of 80 men mostly students, aged 18-42, levels of perceived stress
decreased significantly in the group who received MVM supplementation. The study
incorporated resting blood samples to measure zinc status in participants. Zinc levels increased in
the treatment group, while perceived stress levels decreased, confirming compliance [17].
Another study with positive results for perceived stress collected blood and saliva samples in 59
people aged 18-65. The saliva collected was used to measure cortisol levels and the blood labs
detected over and underconsumption of the supplement [27]. By collecting biological samples
from participants, researchers were able to confirm that protocol was followed.
The literature shows mixed results on whether or not MVM supplementation has an
effect on depression. Like with studies on supplementation and perceived stress, depression
studies also often used multivitamin-mineral supplements that also contained herbal extracts like
ginseng or guarana [11,21,25]. Ginseng is a root of plants in the genus Panax. It has the ability to

26

regulate hormonal changes on the hypothalamic-pituitary-adrenal axis. It also has been proven to
suppress the occurrence of psychological diseases like depression and anxiety [66]. Guarana is
made from the seeds of the guarana plant and is known for its high caffeine content [67].
Caffeine has been linked with increased well-being, improvement in mood, and a reduction in
symptoms of depression [68].
There also is some question of timing as it relates to when mood is measured relative to
intake of the supplement. In a study of MVM supplementation on measures of mood, Pipingas et
al. instructed subjects not to take the supplement before going to the center for each study visit so
that chronic effects of the MVM supplementation could be studied. There was no apparent
impact on any mood measures, including perceived stress and depression [62]. However, as a
sub-part of their study, they sent home participants with weekly mobile at-home mood
assessments and were instructed to take their surveys on multiple occasions after having taken
their daily supplement. This allowed them to more closely study the acute effects the supplement
had on the participants. Results from these assessments showed that current mood during testing
can affect responses. Many of the questions on the surveys asked participants to reflect on their
mood in the last week to answer the questions. However, current mood can alter responses and
not reflect an accurate portrayal of the prior week. The short-term effects of multivitamin
mineral supplements have the potential to improve mental health status as is shown in a study by
Schlebusch et al. with several patients who reported feeling better for a few hours after taking
one [69]. In our study, participants were instructed to take their one at-home final survey within
3 hours of taking their supplement. Taking the supplement within 3 hours of testing would assure
that the acute effects of the MVM could reflect in the survey. However, since this was not

27

monitored, compliance could not be confirmed, making it difficult to know if the supplement had
an effect during testing.

Effect of BMI
Daily MVM supplementation improved ratings of depression at Day 30 for both the
treatment and control group in those with an overweight/obese BMI compared with normal BMI.
The difference between MVM and placebo groups in mean change score was statistically
significant, but it was the placebo group that had the greatest improvement. Hence, MVM was
not better than the placebo in lowering depression scores in people with an overweight/obese
BMI. No other psychological measures were significantly different between the normal weight
and overweight/obese groups. Perhaps the study length or sample size was not long enough to
adequately raise micronutrient levels enough to make a difference.

Strengths
This double blinded, randomized control trial had many strengths. Validated, widely
accepted instruments were used to measure psychological parameters that influence mood. The
study incorporated a wash out period of a week for all participants to stop taking supplements to
minimize any carryover effects of habitual practices into the study period. The target study
population of young adults is a distinct age group not often studied, but very often struggling
with mental health issues [2,30]. This age category is often grouped together with other adults in
research, despite being in a very different life and developmental stage. This study focused only
on 18–25-year-olds. It also encouraged compliance and participation through weekly check-ins
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in person, email reminders, texts, and compensation that was given in stages to promote
completion of study protocols.
The supplement itself was modeled on a promising commercial multivitamin-mineral
product that has shown positive results in several studies [3]. It did not contain added herbal
extracts or caffeine in an effort to isolate the effects of just the vitamins and minerals.
And lastly, this study approach took into account the potential impact that excess body
weight may have in response to MVM supplementation. This enabled exploration of whether
those with excess weight, as defined by having a BMI in the overweight or obese category, are
more likely to respond better than those of normal weight to supplementation in improving
measures of psychological functioning. The need for investigation of the potential modifying
effect of BMI is warranted given that those with excess weight are at higher risk of poorer
psychological functioning and mood as well as higher risk for micronutrient deficiencies.

Limitations
Several important limitations of our study should be noted. Females were overrepresented
in the study with 108 of the 136 or 79%, participants being women. Men and women differ with
their psychological response to stressful events, with women often experiencing greater rates of
depression, anxiety, and stress [61]. With only 12 study participants taking the MVM supplement
being male, the results may not be generalizable. The majority of participants were also college
students, which excludes young adults not in college. College students experience stresses that
are different than young adults who only work or live at home with their parents. Recruiting in
places other than on a college campus could improve generalizability.
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Another limitation is the lack of biochemical measurements, such as urine or blood to
measure compliance or mood-related biomarkers. Compliance was measured by participants
returning to the study office with unused pills and study staff recording the number of pills not
used. Subjects could have forgotten to take pills or taken extra on one day, but report that they
had followed the protocol as instructed and not bring the unused pills to the study office. Also,
there was no way to know if subjects were taking other supplements during the study. If there
had been a fasted blood draw at baseline and 30 days, we could have known their status for
several micronutrients at baseline and then compared that with their Day 30 status to help in
assessing compliance. Knowing baseline status would also provide objective data to identify
whether a participant already had normal levels of micronutrients prior to starting the study
protocol and thus were less likely to respond to supplementation. We would also be able to see
measurements like high blood sugar or caffeine, which would have the potential to skew the
results irrespective of the MVM supplements. In addition, biomarkers like homocysteine and
stress hormones could have been measured as indicators of physiological response to stress.
Surveys were also taken online, unsupervised. Not having anyone watching them,
participants may have rushed or half-heartedly filled out their survey. Another limitation could
be the requirement that all participants stop any supplementations they were taking during and
one week prior to the study. If participants were taking a supplement with potential benefits to
mood like Vitamin D, omega-3 fatty acids, or herbs, removal of the supplement could increase
negative psychological symptomology over time [70,71]. Finally, there is the question of
whether 30 days is long enough for MVM supplementation to have an impact. It may be too
short for the emergence of further treatment-related effects.
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Conclusion
MVM supplementation over 30 days decreased symptoms of anxiety young adults. It
lowered ratings of dysregulation, but more for the placebo group than the treatment group. It also
lowered depression ratings in overweight/obese subjects, but again with lower scores in the
placebo group. Our findings, if replicated, could have useful implications for young adults.
MVM supplements are a simple, cost-effective way to assure proper micronutrient status in a
population that is often deficient [33] and at higher risk for anxiety, depression, and other
psychological impairments [2,8]. Multivitamin-minerals can work quicker and with less effort
than traditional stress management methods.
Future research should include a larger sample size, but still include recruitment by BMI.
Possible inclusion criteria could recruit only participants who had not taken supplements of any
kind over the 6 months to assure no carryover into the study. A longer study of 3 months or more
with both acute and chronic dosing regimens could also help differentiate treatment effects.
Designing the survey in which items get switched to require more participant attention would
minimize the potential of indiscriminate completion of the survey, particularly with subsequent
administration of the survey. Adding a biological component would provide biomarkers to
measure stress levels and give the ability to see micronutrient status. Finally, a focus on less
psychological measures would allow for a shorter survey that could be taken across multiple time
points. This could provide more consistent data to offset having an exceptionally good or bad
mood on test day, which could skew results.
This work was supported by the Arkansas Agricultural Experiment Station, University of
Arkansas Division of Agriculture and the 21st Century Endowed Chair in Human Environmental
Sciences.
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Appendix B
Participant Screening Script and Questionnaire
Hello, my name is ___ and I am a research assistant with the Multivitamin-Mineral
Supplementation study at the University of Arkansas. Is now a good time to talk and give you
some information about the study? (If yes, say thank you and continue on. If no, then ask if there
is a better time to call back).
Thank you very much for your interest in our study. First, I would like to tell you a little about
the study and if you are interested then ask you a few questions to determine if you are eligible to
participate.
This research study is looking at the effects of multivitamin-mineral supplementation on mood
and overall well-being. Participants in this study will be asked to take a daily multivitamin
supplement or placebo for 30 days and complete online questionnaires asking about mood,
physical health and diet, and weight-related health. Your participation would last approximately
32 days and you would be compensated $100 for participating.
Are you still interested? (If they are not interested in participating: Thank you for your time and
interest in the study.)
If yes: Great! We are happy to hear you are interested in participating. We have a few screening
questions that we would like to ask to determine your eligibility in the study. These questions ask
your basic information and if you have any health-related diagnoses that could possibly impair
the effectiveness of the multivitamin supplementation. Do I have your permission to ask these
questions?
Note to research assistants: Please go through the entire screening questionnaire even if they
are disqualified half way through.

Screening Questionnaire
1. What is your name?
2. What is your phone number and email address?
3. What is your preferred method of contact?
4. What is your height?
5. What is your current weight?
6. BMI?
7. Are you between 18 and 24 years old?
Yes

No
40

8. Are you pregnant or planning to become pregnant? (If male, skip this question)
Yes
No
N/A
9. Are you going to school or working at least part-time?
Yes
No
10. Have you ever been diagnosed with malabsorption, or any related gastrointestinal
diagnoses for example, Chron’s disease or inflammatory bowel syndrome?
Yes
No
11. Have you ever received a diagnosis related to impaired liver or renal function?
Yes
No
12. Do you have iron deficiency anemia?
Yes
No
13. Have you ever been diagnosed with a mental health disorder, for example, general
anxiety, depression, bipolar disorder or an eating disorder?
Yes
No
14. Are you currently taking any prescription medications for a mental health diagnosis?
Yes
No
15. Are you willing to abstain from taking any other supplements during the study and
abstain from taking any drugs, including marijuana?
Yes
No
16. Are you extremely uncomfortable or unable to swallow pills?
Yes
No
NOTE: People responding YES to questions 7, 9, 10, 11, 12, 13, and 15 or a NO to question 14
are not eligible for the study.
For those not eligible to participate (answering yes to any of the above disqualifies the
person from participating): I am sorry to inform you that unfortunately you are not eligible to
participate in the Multivitamin-Mineral Supplementation study. Thank you very much for you
interest in participating.

For those eligible to participate: You are eligible to participate in our study! Next, we would
like for you to come to our study laboratory so that we can obtain your informed consent, explain
the study instructions, and get some further background information from you. Our study
laboratory is located on the 2nd floor of the Home Economic building in office 205D on the
University of Arkansas campus. When would be a good time for you to come in? (Schedule a
date and time).
We appreciate your interest in the multivitamin-mineral supplementation study and we look
forward to meeting you on (date) and (time). If you have any questions or trouble locating our
lab, please do not hesitate to contact me at _______________.
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Appendix C
Participant Informed Consent Form
Multivitamin-Mineral Supplementation & Mood Study
Consent to Participate in a Research Study
Principal Researcher: Jennifer Becnel, PhD & Sabrina Trudo, PhD, RD
INVITATION TO PARTICIPATE
You are invited to participate in a research study investigating the effects of multivitaminmineral supplementation on your health. You are being asked to participate in this study because
you are between the ages of 18 and 24 years old, going to school or working at least part-time,
and have no gastrointestinal or mental health diagnoses. Please take time to review the following
form, ask questions, and decide whether you wish to participate or not.
WHAT YOU SHOULD KNOW ABOUT THE RESEARCH STUDY
Who are the Principal Researchers?
This study is being conducted by Jennifer Becnel, PhD and Sabrina Trudo, PhD, RD of the
School of Human Environmental Sciences at the University of Arkansas. Dr. Becnel can be
reached by phone at 479-575-2358 or by email at becnel@uark.edu. Dr. Trudo can be reached by
phone at 479-575-4863 or by email at trudo@uark.edu.
What is the purpose of this research study?
Poor health and mood have been associated with micronutrient deficiencies. The purpose of this
study is to examine the effects of multivitamin-mineral supplementation on mood, health, and
weight-related satisfaction in young adults.
Who will participate in this study?
This study will include 140 young adult men and women. To participate, you must be the ages of
18-24, going to school or working at least part-time, have no malabsorption or related
gastrointestinal diagnosis, no mental health diagnosis, and not taking prescription medications.
You must be willing to take only the provided multivitamin-mineral supplement for 30 days.
What am I being asked to do?
During your first visit to the study laboratory, study staff will explain the study and address any
questions or concerns you may have. If you agree to participate, study staff will take your height
and weight and outline a detailed schedule for your participation in the study. You will also fill
out a short questionnaire asking basic questions about yourself. At this time, we ask that you
discontinue use of dietary/herbal supplements (including all vitamins and teas).
Participation in this study will last 31 days. You will be randomly assigned to take two pills daily
for a month of either a multivitamin-mineral supplement or placebo (not containing any vitamins
or minerals). You will not know if you are assigned to take the multivitamin-mineral supplement
or the placebo. During the 31 days, you will be asked to visit the study laboratory weekly (every
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7 days) to pick up the multivitamin-mineral supplements or placebo. The multivitamin-mineral
supplement or placebo is to be taken every morning at approximately the same time.
Additionally, you are asked to complete two online questionnaires on five assessment days: Day
1, Day 3, Day 4, Day 15, and Day 30. The first online questionnaire will ask questions about
psychological functioning, health, and weight-related satisfaction. The second online
questionnaire will ask about your dietary intake in the previous 24 hours. The questionnaires
should take approximately one hour to complete, total. On the last day of the study, you will be
asked to return to the study laboratory to have your height and weight taken again. Below is an
outline of the study schedule.
Study Schedule
Day 0:
Return to the study laboratory to pick up the supplements/placebo. You will be
given 7 days’ worth of the supplement/placebo.
Day 1:
Begin taking the supplement/placebo in the morning and complete the online
assessments within 3 hours of taking the supplement/placebo.
Day 3:
Complete the online assessments within 3 hours of taking the
supplement/placebo.
Day 4:
Complete online assessment before taking the supplement/placebo.
Day 7:
Return to the study laboratory for another week’s supply of the
supplement/placebo.
Day 14:
Return to the study laboratory for another week’s supply of the
supplement/placebo.
Day 15:
Complete the online assessments within 3 hours of taking the
supplement/placebo.
Day 21:
Return to the study laboratory for another week’s supply of the
supplement/placebo.
Day 30:
Complete the online assessments within 3 hours of taking the
supplement/placebo.
Day 31:
Return to the study laboratory to finish out the study and have your height and
weight taken.
What are the possible risks or discomforts?
You may feel uncomfortable answering some of the questions in the online questionnaire. If you
feel any discomfort, you can omit an answer to a question or terminate your involvement in the
study. You will not be penalized for omitting answers or terminating the questionnaires early.
There may be discomfort from swallowing the supplement/placebo pills if you are not
accustomed to swallowing pills. If you find that you cannot tolerate swallowing pills, you do not
have to complete the study. The amounts of the vitamins and minerals in the supplement are
similar to supplements that are available for purchase at stores.
What are the possible benefits of this study?
There are no benefits to participating in the study.
Will I receive compensation for my time and inconvenience if I choose to participate in this
study?
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You will receive a total of $100 in cash for completing the study, distributed as each assessment
day is completed. Compensation is received for each day the online questionnaires are
completed. Amounts increase for each questionnaire day (Day 1 = $10, Day 3 = $15, Day 4 =
$20, Day 15 = $25, Day 31 = $30). To minimize the number of times you need to visit the
laboratory, compensation will be dispersed on Day 7, Day 21, and Day 31.
Will I have to pay for anything?
There will be no cost associated with your participation in this study.
What are the options if I do not want to be in the study?
If you do not want to be in this study, you may refuse to participate. Also, you may refuse to
participate at any time during the study. Your standing and relationship with the University of
Arkansas will not be affected in any way if you refuse to participate or drop out of the study.
How will my confidentiality be protected?
All information will be kept confidential to the extent allowed by applicable State and Federal
law. Participants in this study will be assigned an ID number to ensure confidentiality. A master
list linking participant’s names to ID numbers and all participant data will be kept on a secure
server that only the study staff will have access to.
Will I know the results of the study?
At the conclusion of the study you will have the right to request feedback about the results. You
may contact the Principal Researcher, Jennifer Becnel at becnel@uark.edu or 479.575.2358. You
will receive a copy of this form for your files.
What do I do if I have questions about the research study?
You have the right to contact the Principal Researcher as listed below for any concerns that you
may have.
Jennifer Becnel, PhD
Assistant Professor of Human Development and Family Sciences
Human Environmental Sciences
HOEC 118
1 University of Arkansas
Fayetteville, AR 72701
479.575.2358
Becnel@uark.edu
Sabrina Trudo, PhD, RD
Associate Professor of Nutrition
21st Century Endowed Chair in Human Environmental Sciences
HOEC 118
1 University of Arkansas
Fayetteville, AR 72701
Tel: 479.575.4863
trudo@uark.edu
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You may also contact the University of Arkansas Research Compliance office listed below if you
have questions about your rights as a participant, or to discuss any concerns about, or problems
with the research.
Ro Windwalker, CIP
Institutional Review Board Coordinator
Research Compliance
University of Arkansas
109 MLKG Building
Fayetteville, AR 72701-1201
479-575-2208
irb@uark.edu
STATEMENT OF CONSENT
I have read the above statement and have been able to ask questions and express concerns, which
have been satisfactorily responded to by the investigator. I understand the purpose of the study as
well as the potential benefits and risks that are involved. I understand that participation is
voluntary. I understand that no rights have been waived by signing the consent form. I have been
given a copy of the consent form.
Name of Participant: ________________________
Signature of Participant: ______________________
Signature of Investigator: _____________________
Date: ______________
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Appendix D
Participant Instruction Booklet

Multivitamin-Mineral
Supplementation & Mood Study
Participant Instruction Booklet
For questions about any part of the study, please contact your study coordinator.
Study Coordinator: Sharon Chang
Laboratory: HOEC 205D
Research Coordinator: ______________________
Coordinator Phone Number: _____________________
Emergencies—Dr. Becnel
(480) 276-2955
Email
Yc031@uark.edu

Please stop taking all medications and dietary/herbal supplements (including all
vitamins and teas) beginning one week before the study period.
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Stop on:_________________

Purpose of the Study
The primary purpose of this study is to examine the effects of a multivitamin-mineral
supplement (MVM) on psychological functioning, health, and weight-related satisfaction among
young adult college students.

Study Procedures and Time Commitment
This is a research study looking at the effects of Multivitamin-Mineral Supplementation on
mood and overall well-being. The total timeline for the project is two years, during which we
will conduct a randomized controlled trial at the University of Arkansas, Fayetteville. However,
you are required to participate in the study only for 31-days.
You may qualify for the study if you are/have:
• 18 – 24 years old;
• Going to school or working at least part-time;
• No diagnosis of malabsorption or related gastrointestinal diagnoses (e.g., Crohn’s
disease, inflammatory bowel disease);
• No diagnosis related to impaired liver or renal function;
• No mental health diagnosis (e.g., general anxiety disorder, depression, bipolar-related
diagnoses);
• Not taking prescription medications for mental health diagnoses;
• And willing to not take any other supplements during the study.
After the screening interview over the phone, if you qualify, you will be asked to come to the
study laboratory to have your height and weight taken, fill out a one-time demographic
questionnaire, and be given the study instructions and activities. At this time, we will randomly
assign you to either the MVM supplement or placebo group. The following week, you will
return to the study laboratory to receive a week’s supply of the supplement or placebo pills and
will be instructed to take two pills at approximately the same time every morning. You will
return to the study laboratory once a week for another week’s supply of the supplement or
placebo pills and to return any pills that you did not take during the previous week.
You will also be asked to complete the following two questionnaires on each of the
five assessment days: Consent Day, Day 3, Day 4, Day 15, and Day 31. They are,
1. Questionnaire- I: A self-administered online questionnaire to
assess your psychosocial functioning, health indicators, and weight related satisfaction. It is
a set of questionnaires that will be presented in a random order each time
through Qualtrics software.
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2. Questionnaire- II: A self-administered online questionnaire, ASA24®, to assess your
dietary intake in the previous 24 hours. ASA24® is completed separately using a website and
confidential login from the National Cancer Institute.
You will be instructed to complete the questionnaires within three hours after taking the
supplement or placebo on Day--3, Day 15, and Day 31. However, on Day 4 you will be required
to complete the questionnaires before taking the supplement. Links to the questionnaires will
be provided to you and you will be reminded to complete the questionnaires via text, email, or
phone calls.

Coming to HOEC
The Home Economics (HOEC) building is located on the University of Arkansas, Fayetteville
campus. The study office is located on the 3rd floor of HOEC in 205D.

Supplement
The Multivitamin-Mineral Supplement that we are using in this study was formulated to contain
selective nutrients such as B vitamins, vitamin C, calcium, magnesium, and zinc and no
additional compounds such as herbals. The composition of MVM supplement is given in the
table below. We will randomly assign you either to an MVM supplement group or a placebo
group. You will be asked to take two pills at a time each day. For research purposes, we will
make both the supplement and placebo pills look exactly the same and you will not know
whether you are taking MVM pills or placebo pills.
Supplement packets can be picked up from the study laboratory every Tuesday. Please bring
back the empty supplement packs from the week prior when you pick up the new pack for the
next week.
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Vitamin/Mineral
B1 = Thiamin
B2 = Riboflavin
B3 = Nicotinamide
B5 = Pantothenic Acid
B6
B12
C
H = Biotin
Folic Acid
Calcium
Magnesium
Zinc

Amount in
Supplement
15 mg
15 mg
50 mg
23 mg
10 mg
10 µg
500 mg
150 µg
400 µg
100 mg
100 mg
10 mg

RDA

%RDA

1.1 – 1.2 mg
1.1 – 1.3 mg
14 – 16 mg
5 mg
1.3 mg
2.4 µg
75 – 90 µg
30 µg
400 µg
1,000 mg
310 – 400 mg
8 – 11 mg

1364
1364
357
460
769
416
667
500
100
10
32
125

Questionnaires
You will be asked to complete questionnaire-I and questionnaire-II on each of the five
assessment days. In addition, you will be asked to complete one time questionnaires on
demographics and alcohol consumption at the start of the study.
Demographics:
A demographic questionnaire will ask about age, gender/sex, year and full or part time in
college, socioeconomic status and work status, geographic location (urban vs. rural), food
insecurity, Greek life engagement, general eating behaviors, and sleep behaviors.
Alcohol Use:
Participants will complete 6 questions from National Institute on Alcohol Abuse and Alcoholism
(NIAAA) on frequency of drinking and binge drinking behaviors.
Questionnaire-I:
Questionnaire-I is a compilation of several mini questionnaires to assess psychological
functioning, weight related functioning and health measures.
1). Psychological Functioning Measures:
BAI (Beck Anxiety Inventory): The BAI evaluates physiological and cognitive symptoms of
anxiety.
Center for Epidemiologic Studies Depression Scale (CES-D): The CES-D is a brief assessment
measuring attitudes and symptoms of depression.
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Self-Esteem: A single item measures self-esteem or your feelings about yourself.
ADI (Abbreviated Dysregulation Inventory): The ADI evaluates ability to control thoughts,
feelings, and behavior.
PSS (Perceived Stress Scale): The PSS assesses feelings and thoughts related to stress and
coping.
2). Weight-Related Functioning Measures:
IWQOL-Lite (Impact of Weight on Quality of Life-Lite): The IWQOL-Lite assesses the impact
of obesity on quality of life in areas of physical functioning, self-esteem, public distress, and
work.
BSQ (Body Shape Questionnaire): The BSQ measures individuals’ self-perception
of their body shape and body satisfaction/dissatisfaction.
3). Health Measures:
HRQOL (CDC Health Related Quality of Life-14 Measure): The HRQOL is a measure
developed by the Centers for Disease Control to assess health related to physical,
emotional, and social functioning.
IPAQ (International Physical Activity Questionnaire): The IPAQ measures health-related
physical activity.
Questionnaire-II:
ASA24® (Automated Self-Administered 24-Hour Dietary Assessment Tool): The ASA24® was
developed by the National Cancer Institute and assesses what was eaten over the previous 24hour period.
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Detailed Schedule of Study Activities
Day
Consent

Day 0
Day 1
Day 3
Day 4

Day 7
Day 14
Day 15
Day 21
Day 30
Day 31
•
•

period

Date

Instructions
Complete
Agree to participate in study;
Questionnaire I
measurements taken; complete
Questionnaire II
questionnaires
Pick up supplements from study lab
Begin taking the supplement in the
morning
Complete the online questionnaires within Questionnaire I
3 hours of taking the supplement
Questionnaire II
Complete the online
Questionnaire I
questionnaires before taking
Questionnaire II
the supplement
Return to the study lab for another week’s
supply of the supplement & return any
unused supplements
Return to the study lab for another week’s
supply of the supplement & return any
unused supplements
Complete the online questionnaires within Questionnaire I
3 hours of taking the supplement
Questionnaire II
Return to the study lab for another week’s
supply of the supplement & return any
unused supplements
Complete the online questionnaires within Questionnaire I
3 hours of taking the supplement
Questionnaire II
Return to the study lab to finish out the
study & return any unused supplements

Take 2 pills at a time every day throughout the study period
Avoid herbal supplements, herbal teas and other vitamin-mineral supplements during the study

Things to Avoid During the Study
You will be asked not to take any other vitamin, mineral and herbal supplements and teas as
well as herbal teas during the study. You should let us know if a medication is started for a
mental or physical health-related diagnosis any time during the study.

Compensation
Thank you for your interest in participating in the Multivitamin-Mineral Supplementation &
Mood Study. You will receive a total of $100 in cash as a stipend to compensate you for your
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time, effort, and inconvenience related to completing the study. This stipend will be distributed
incrementally as assessments are completed. Cash is received for each day the online
questionnaires are completed. Amounts increase for each questionnaire day (Day 1 = $10, Day
3 = $15, Day 4 = $20, Day 15 = $25, Day 31 = $30). Stipends can be picked up from the
study laboratory on Day 7, Day 21, and Day 31.

Questions and Contact Information
If you have any questions at any time, you can contact the study coordinator,
Ryan Grant at 479-575-7538. The researchers conducting this study are Jen Becnel, PhD and
Sabrina Trudo, PhD, RD. If you have any questions for them, you can contact Dr. Becnel at 479575-2358 and Dr. Trudo at 479-575-4863. If you have any questions or concerns about your
rights as a research participant, then you are encouraged to contact Ro Windwalker at 479-5752208.

Services Available for Discomfort Experienced during the Questionnaire
The online questionnaires that you are asked to take ask questions regarding depression,
anxiety, and how you feel about yourself. If you experience any discomfort while answering
these questions, please do not hesitate to contact Counseling and Psychological Services (CAPS)
here on campus at 479.575.5276.
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Appendix E
Demographic Baseline Questionnaire.
This is the complete questionnaire participants took at baseline. A slightly modified version was
completed on the final day of participation which excluded the following blocks: demographics,
parent education, food insecurity, sleep, alcohol, and eating behavior.

MVM Demographics
Q19 Welcome to the Multivitamin-Mineral Supplementation study!
This study is investigating multivitamin-mineral supplementation and mood. We would
appreciate you taking about 15 minutes to complete the following survey. Be assured that all
answers you provide will be kept in the strictest confidentiality. Any personal information
obtained is for linking participants across surveys and will not be shared. Please click the red
arrow button to begin.
Q21 What is your first and last name?
Q3 What is your age in years?
Skip To: End of Survey If Condition: What is your age in years? Is Greater Than 25. Skip To: End of Survey.
Skip To: End of Survey If Condition: What is your age in years? Is Less Than 18. Skip To: End of Survey.

Q5 What is your gender?

o Male (1)
o Female (2)
o Other (3)
Q9 Are you a full-time or part-time student?

o Full-time (1)
o Part-time (2)
o Not a student (3)
Skip To: Q11 If Are you a full-time or part-time student? = Not a student
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Q7 What year are you in college?

o Freshman (1)
o Sophomore (2)
o Junior (3)
o Senior (4)
o Graduate Student (5)
o Not a college student (6)
Q11 What is your highest level of education completed?

o Some high school (1)
o High school (2)
o Some college (3)
o Associate's degree (4)
o Bachelor's degree (5)
o Post graduate degree (6)
Q13 What is your employment status?

o Full-time (1)
o Part-time (2)
o Unemployed (3)

Q15 What is your geographic living location?

o Urban (1)
o Rural (2)
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Q17 Are you currently or were you ever involved in Greek life?

o Yes (1)
o No (2)

Q12 What is the highest level of education your mother completed?

o 8th grade or less (1)
o Some high school (2)
o High school degree (3)
o Completed vocational/technical training (4)
o Some college (5)
o College degree (bachelor's) (6)
o Some graduate school (7)
o Completed master's or doctoral degree (8)
Q14 What is the highest level of education your father completed?

o 8th grade or less (1)
o Some high school (2)
o High school degree (3)
o Completed vocational/technical training (4)
o Some college (5)
o College degree (bachelor's) (6)
o Some graduate school (7)
o Completed master's or doctoral degree (8)
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Q16 In the last 12 months, the food that I/we bought just didn't last, and I/we didn't have money
to get more.

o Often True (1)
o Sometimes True (2)
o Never True (3)
o Don't Know (4)
Q18 In the last 12 months, I/We couldn't afford to eat balanced meals.

o Often True (1)
o Sometimes True (2)
o Never True (3)
o Don't know (4)
Q22 In the last 12 months, did you ever eat less than you felt you should because there wasn't
enough money for food?

o Yes (1)
o No (2)
o Don't know (3)
Q20 In the last 12 months, were you ever hungry but didn't eat because there wasn't enough
money for food?

o Yes (1)
o No (2)
o Don't know (3)
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Q21 In the last 12 months, did you or other adults in your household ever cut the size of your
meals or skip meals because there wasn't enough money for food?

o Yes (1)
o No (2)
o Don't know (3)
Skip To: End of Block If In the last 12 months, did you or other adults in your household ever cut the size of your
meals... = No
Skip To: End of Block If In the last 12 months, did you or other adults in your household ever cut the size of your
meals... = Don't know

Q23 How often in the last 12 months did you or other adults in your household ever cut the size
of your meals or skip meals because there wasn't enough money for food?

o Almost every month (1)
o Some months but not every month (2)
o Only 1 or 2 months (3)
o Don't know (4)
Q61 During the past month when have you usually gone to bed?
________________________________________________________________

Q62 During the past month how long (in minutes) has it taken you to fall asleep each night?
▼ 5 minutes (2) ... 60 minutes or more (13)

Q63 During the past month, what time have you usually gotten up in the morning?
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Q64 The following questions relate to your usual sleep habits during the past month only. Please
indicate the most accurate reply for the majority of days and night in the past month.

o How many hours of actual sleep did you get at night? (1)
________________________________________________

o How many hours were you in bed? (2)

________________________________________________
Q65
During the past month, how often have you had trouble sleeping because you:
Not during the
past month (1)

Less than once a
week (2)

Once or twice a
week (3)

Three or more
times a week (4)

Cannot get to
sleep within 30
minutes (2)

o

o

o

o

Wake up in the
middle of the
night or early
morning (3)

o

o

o

o

Have to get up to
use the bathroom
(4)

o

o

o

o

o
o
o
o
o
o
o

o
o
o
o
o
o
o

o
o
o
o
o
o
o

o
o
o
o
o
o
o

Cannot breathe
comfortably (5)
Cough or snore
loudly (6)
Feel too cold (7)
Feel too hot (8)
Have bad dreams
(9)
Have pain (10)
Other reason (11)
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Q66 During the past month, how often have you taken medicine (prescribed or "over the
counter") to help you sleep?

o Not during the past month (1)
o Less than once a week (2)
o Once or twice a week (3)
o Three or more times a week (4)
Q67 During the past month, how often have you had trouble staying awake while driving, eating
meals, or engaging in social activity?

o Not during the past month (1)
o Less than once a week (2)
o Once or twice a week (3)
o Three or more times a week (4)
Q68 During the past month, how much of a problem has it been for you to keep up enthusiasm to
get things done?

o Not during the past month (1)
o Less than once a week (2)
o Once or twice a week (3)
o Three or more times a week (4)

Q69 During the past month, how would you rate your sleep quality overall?

o Very good (1)
o Fairly good (2)
o Fairly bad (3)
o Very bad (4)
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Q20 During the last 12 months, how often did you usually have any kind of drink containing
alcohol? By a drink we mean half an ounce of absolute alcohol (e.g. a 12oz can or glass of
beer or cooler, a 5oz glass of wine, or a drink containing 1 shot of liquor). Choose only one.

o Every day (1)
o 5 to 6 times a week (2)
o 3 to 4 times a week (3)
o Twice a week (4)
o Once a week (5)
o 2 to 3 times a month (6)
o Once a month (7)
o 3 to 11 times in the past year (8)
o 1 or 2 times in the past year (9)
o I did not drink any alcohol in the past year, but I did drink in the past (10)
o I have never drank any alcohol in my life (11)
Skip To: Q22 If During the last 12 months, how often did you usually have any kind of drink containing alcohol? B...
= I did not drink any alcohol in the past year, but I did drink in the past
Skip To: Q24 If During the last 12 months, how often did you usually have any kind of drink containing alcohol? B...
= I have never drank any alcohol in my life
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Q26 During the last 12 months, how many alcoholic drinks did you have on a typical day when
you drank alcohol?

o 25 or more drinks (1)
o 19 to 24 drinks (2)
o 16 to 18 drinks (3)
o 12 to 15 drinks (4)
o 9 to 11 drinks (5)
o 7 to 8 drinks (6)
o 5 to 6 drinks (7)
o 3 to 4 drinks (8)
o 2 drinks (9)
o 1 drink (10)
Q28 During the last 12 months, what is the largest number of drinks containing alcohol that you
drank within a 24-hour period?

o 36 drinks or more (1)
o 24 to 35 drinks (2)
o 18 to 23 drinks (3)
o 12 to 17 drinks (4)
o 8 to 11 drinks (5)
o 5 to 7 drinks (6)
o 4 drinks (7)
o 3 drinks (8)
2 drinks (9)
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o 1 drink (10)
Q30 During the last 12 months, how often did you drink this largest number of drinks? Choose
only one.

o Every day (1)
o 5 to 6 times a week (2)
o 3 to 4 times a week (3)
o Twice a week (4)
o Once a week (5)
o 2 to 3 times a month (6)
o Once a month (7)
o 3 to 11 times in the past year (8)
o 1 or 2 times in the past year (9)
Q32 During the last 12 months, how often did you have 5 or more (males) or 4 or more (females)
drinks containing any kind of alcohol within a two-hour period? (That would be the equivalent of
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at least 5 (4) 12oz cans or bottles of beer, 5 (4) 5oz glasses of wine, 5 (4) drinks each containing
once shot of liquor or spirits.) Choose only one response.

o Every day (1)
o 5 to 6 days a week (2)
o 3 to 4 days a week (3)
o Two days a week (4)
o One day a week (5)
o 2 to 3 days a month (6)
o One day a month (7)
o 3 to 11 days in the past year (8)
o 1 or 2 days in the past year (9)
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = Every day
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = 5 to 6 days a week
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = 3 to 4 days a week
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = Two days a week
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = One day a week
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = 2 to 3 days a month
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = One day a month
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = 3 to 11 days in the past year
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more
(females) drinks... = 1 or 2 days in the past year
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Q24 So you have never had a drink containing alcohol in your entire life.

o Correct, I have never drank (1)
o No, I did drink (2)
Skip To: Q22 If So you have never had a drink containing alcohol in your entire life. = No, I did drink
Skip To: End of Block If So you have never had a drink containing alcohol in your entire life. = Correct, I have
never drank

Q22 During your lifetime, what is the maximum number of drinks containing alcohol that you
drank within a 24-hour period?

o 36 drinks or more (1)
o 24 to 35 drinks (2)
o 18 to 23 drinks (3)
o 12 to 17 drinks (4)
o 8 to 11 drinks (5)
o 5 to 7 drinks (6)
o 4 drinks (7)
o 3 drinks (8)
o 2 drinks (9)
o 1 drink (10)
Q29 During the past 6 months, have you had times when you eat continuously during the day or
parts of the day without planning what and how much you would eat?

o Yes (1)
o No (2)
Skip To: Q27 If During the past 6 months, have you had times when you eat continuously during the day or parts
of... = Yes
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Q27 Did you experience a loss of control, that is, you felt like you could not control your eating?

o Yes (1)
o No (2)

Q39 In the past 3 months, have you had any episodes of binge eating?

o Yes (1)
o Maybe (2)
o No (3)

Q38 During the past 3 months, how often did you keep eating a meal even though you were not
hungry anymore?

o Never (1)
o Rarely (one per month or less) (2)
o Occasionally (once per week) (3)
o Most of the time (multiple times per week) (4)

Q31 In the past 3 months, how often did you keep eating a meal even though you felt full?

o Never (1)
o Rarely (once per month or less) (2)
o Occasionally (once per week or more) (3)
o Most of the time (multiple times per week) (4)

Q33 During the past 3 months, how much of your daily food intake did you consume after
suppertime?

o 0 (none) (1)
o 1-25% (up to a quarter) (2)
o 26-50% (about half) (3)
o 51-75% (more than half) (4)
76-100% (almost all) (5)

65

Q35 During the past 3 months, how often did you get up (at least once) in the middle of the night
other than [having] to use the bathroom?

o Never (1)
o Less than once a week (2)
o About once a week (3)
o More than once a week (4)
o Every night (5)

Q37 During the past 3 months, how often would you have a snack in the middle of the night?

o Never (1)
o Sometimes (2)
o About half the time (3)
o Usually (4)
o Always (5)
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Q41 Below is a
list of common
symptoms of
anxiety. Please
carefully read each
item in the list.
Indicate how
much you have
been bothered by
that symptom
during the past
week, including
today.
Numbness or
Tingling (1)
Feeling hot (2)
Wobbliness in legs
(3)
Unable to Relax
(4)
Fear of worst
happening (5)
Dizzy or
lightheaded (6)
Heart
pounding/racing
(7)
Unsteady (8)
Terrified or afraid
(9)
Nervous (10)
Feeling of choking
(11)

Not at all (1)

Mildly, but it
didn't bother me
much (2)

Moderately- it
wasn't pleasant at
times (3)

Severely- it
bothered me a lot
(4)

o
o
o
o
o
o

o
o
o
o
o
o

o
o
o
o
o
o

o
o
o
o
o
o

o

o

o

o

o
o
o
o

o
o
o
o

o
o
o
o

o
o
o
o
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Hands trembling
(12)
Shaky/unsteady
(13)
Fear of losing
control (14)
Difficulty in
breathing (15)
Fear of dying (16)
Scared (17)
Indigestion (18)
Faint/lightheaded
(19)
Face flushed (20)
Hot/cold sweats
(21)

o
o
o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
o
o
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Q43 Below is a list of ways you might have felt or behaved. Please indicate how often you have
felt this way during the last week.
Rarely or none of
the time (less than
1 day) (1)

Some or a little of
the time (1-2
days) (2)

Occasionally or a
moderate amount
of time (3-4 days)
(3)

All of the time (57 days) (4)

I was bothered by
things that usually
don't bother me.
(1)

o

o

o

o

I had trouble
keeping my mind
on what I was
doing. (2)

o

o

o

o

I felt depressed.
(3)

o

o

o

o

I felt that
everything I did
was an effort. (4)

o

o

o

o

I felt hopeful
about the future.
(5)

o

o

o

o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

I felt fearful. (6)
My sleep was
restless. (7)
I was happy. (8)
I felt lonely. (9)
I could not "get
going." (10)

Q45 I have high self-esteem
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o Strongly Agree (1)
o Agree (2)
o Neutral (3)
o Disagree (4)
o Strongly disagree (5)
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Q47 Below is a
series of statements.
Indicate how often
they are true of you
by choosing the
option that best
describes you.

Never true (1)

Occasionally true
(2)

Mostly true (3)

Always
true (4)

I have difficulty
remaining seated at
school or at home
during dinner. (1)

o

o

o

o

I get very fidgety
after a few minutes
if I am supposed to
sit still. (2)

o

o

o

o

I have difficulty
keeping attention on
tasks. (3)

o

o

o

o

I get into arguments
when people
disagree with me.
(4)

o

o

o

o

Little things or
distractions throw
me off. (5)

o

o

o

o

I can’t seem to stop
moving. (6)

o

o

o

o

Most of the time I
don't pay attention
to what I am doing.
(7)

o

o

o

o

o
o

o
o

o
o

o
o

o

o

o

o

I get bored easily.
(8)
I am easily
distracted. (9)
I spend money
without thinking
about it first. (10)
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Q49 Below is a series of statements. Indicate how often they are true of you by choosing the
option that best describes you.
Never true (1)

Occasionally true
(2)

Mostly true (3)

Always true (4)

I develop a plan
for all my
important goals.
(1)

o

o

o

o

I put my plans
into action. (2)

o

o

o

o

I think about the
future
consequences of
my actions. (3)

o

o

o

o

Once I have a goal
I make a plan to
reach it. (4)

o

o

o

o

o

o

o

o

I consider what
will happen before
I make a plan. (6)

o

o

o

o

I think about my
mistakes to make
sure they don't
happen again. (7)

o

o

o

o

I spend time
thinking about
how to reach my
goals. (8)

o

o

o

o

Failure at a task or
in school makes
me work harder.
(9)

o

o

o

o

I stick to a task
until it is finished.
(10)

o

o

o

o

As soon as I see
things are not
working, I do
something about
it. (5)

Q51 Below is a series of statements. Indicate how often they are true of you by choosing the
option that best describes you.
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Never True (1)

Occasionally True
(2)

Mostly True (3)

Always True (4)

I have trouble
controlling my
temper. (1)

o

o

o

o

I lose sleep
because I worry.
(2)

o

o

o

o

When I am angry
I lose control over
my actions. (3)

o

o

o

o

o

o

o

o

I "fly off the
handle" for no
good reason. (5)

o

o

o

o

There are days
when I'm "on
edge" all the time.
(6)

o

o

o

o

I easily become
emotionally upset
when I am tired.
(7)

o

o

o

o

Often I am afraid I
will lose control
of my feelings. (8)

o

o

o

o

o

o

o

o

o

o

o

o

I get so frustrated
that I often feel
like a "bomb
ready to explode."
(4)

I slam doors when
I am mad. (9)
My mood goes up
and down without
reason. (10)

73

Q52 The
questions in
this scale ask
you about your
feelings and
thoughts
during the last
week. In each
case, you will
be asked to
indicate how
often you felt
or thought a
certain way.
How often
have you been
upset because
of something
that happened
unexpectedly?
(1)
How often
have you felt
that you were
unable to
control the
important
things in your
life? (2)
How often
have you felt
nervous and
“stressed”? (3)
How often
have you felt
confident
about your
ability to
handle your
personal
problems? (4)
How often
have you felt
that things
were going
your way? (5)

Never (1)

Almost Never
(2)

Sometimes (3)

Fairly Often
(4)

Very Often (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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How often
have you
found that you
could not cope
with all the
things that you
had to do? (6)

o

o

o

o

o

How often
have you been
able to control
irritations in
your life? (7)

o

o

o

o

o

How often
have you felt
that you were
on top of
things? (8)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

How often
have you been
angered
because of
things that
were outside of
your control?
(9)
How often
have you felt
difficulties
were piling up
so high that
you could not
overcome
them? (10)
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Q54 Would you say that in general your health is

o Excellent (1)
o Very good (2)
o Good (3)
o Fair (4)
o Poor (5)
o Don't know/Not sure (6)
Q56 Now thinking about your physical health, which includes physical illness and injury, for
how many days during the past 30 days was your physical health not good?
0

3

6

9

12 15 18 21 24 27 30

Number of days ()

Q58 Now thinking about your mental health, which includes stress, depression, and problems
with emotions, for how many days during the past 30 days was your mental health not good?
0

3

6

9

12 15 18 21 24 27 30

Number of days ()

Q60 During the past 30 days, for about how many days did poor physical or mental health keep
you from doing your usual activities, such as self-care, work, or recreation?
0

3

6

9

12 15 18 21 24 27 30

Number of days ()

Q62 Are you LIMITED in any way in any activities because of any impairment or health
problem?

o Yes (1)
o No (2)
o Don't know/Not sure (3)
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Skip To: End of Block If Are you LIMITED in any way in any activities because of any impairment or health
problem? = No

Q64 For HOW LONG have your activities been limited because of your major impairment or
health problem?

o Days (1)
o Weeks (2)
o Months (3)
o Years (4)
o Don't know/not sure (5)
Q66 Because of any impairment or health problem, do you need the help of other persons with
your PERSONAL CARE needs, such as eating, bathing, dressing, or getting around the house?

o Yes (1)
o No (2)
o Don't know/not sure (3)
Q68 Because of any impairment or health problem, do you need the help of other persons in
handling your ROUTINE needs, such as everyday household chores, doing necessary business,
shopping, or getting around for other purposes?

o Yes (1)
o No (2)
o Don't know/not sure (3)
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Q70 Over the
last week, how
true are the
following
statements:

Never true (1)

Rarely true (2)

Occasionally
true (3)

Often true (4)

Always true
(5)

Because of my
weight, I have
trouble picking
up objects. (1)

o

o

o

o

o

Because of my
weight, I have
trouble tying
my shoes. (2)

o

o

o

o

o

Because of my
weight, I have
difficulty
getting up
from chairs.
(3)

o

o

o

o

o

o

o

o

o

o

Because of my
weight, I have
difficulty
putting on or
taking off my
clothing. (5)

o

o

o

o

o

Because of my
weight, I have
trouble with
mobility. (6)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Because of my
weight, I have
trouble using
stairs. (4)

Because of my
weight, I have
trouble
crossing my
legs. (7)
I feel short of
breath with
only mild
exertion. (8)
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I am troubled
by painful or
stiff joints. (9)

o

o

o

o

o

My ankles and
lower legs are
swollen at the
end of the day.
(10)

o

o

o

o

o

I am worried
about my
health. (11)

o

o

o

o

o

79

Q72 Over the
last week, how
true are the
following
statements:

Because of my
weight, I am
self-conscious.
(1)

Never true (1)

Rarely true (2)

Occasionally
true (3)

Often true (4)

Always true
(5)

o

o

o

o

o

o

o

o

o

o

Because of my
weight, I feel
unsure of
myself. (3)

o

o

o

o

o

Because of my
weight, I don't
like myself. (4)

o

o

o

o

o

Because of my
weight, I am
afraid of being
rejected. (5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Because of my
weight, my
self-esteem is
not what it
could be. (2)

Because of my
weight, I avoid
looking in
mirrors or
seeing myself
in
photographs.
(6)
Because of my
weight, I am
embarrassed to
be seen in
public places.
(7)
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Because of my
weight, I do
not enjoy
sexual activity.
(8)
Because of my
weight, I have
little or no
sexual desire.
(9)
Because of my
weight, I have
difficulty with
sexual
performance.
(10)
Because of my
weight, I avoid
sexual
encounters
whenever
possible. (11)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q74 Over the
last week, how
true are the
following
statements:

Because of my
weight, I worry
about fitting
into seats in
public places
(e.g., theaters,
restaurants,
cars, airplanes).
(1)

Never true (1)

Rarely true (2)

Occasionally
true (3)

Usually true
(4)

Always true
(5)

o

o

o

o

o

o

o

o

o

o

Because of my
weight, I worry
about finding
chairs that are
strong enough
to hold my
weight. (3)

o

o

o

o

o

Because of my
weight, I
experience
ridicule,
teasing, or
unwanted
attention. (4)

o

o

o

o

o

Because of my
weight, I
experience
discrimination
by others. (5)

o

o

o

o

o

Because of my
weight, I worry
about fitting
through aisles
or turnstiles.
(2)
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Because of my
weight, I have
trouble getting
things
accomplished
or meeting my
responsibilities.
(6)
Because of my
weight, I am
less productive
than I could be.
(7)
Because of my
weight, I don’t
receive
appropriate
raises,
promotions, or
recognition at
work. (8)
Because of my
weight, I am
afraid to go on
job interviews
(9)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q76 Over the past FOUR WEEKS:

Never (1)

Rarely (2)

Sometimes
(3)

Often (4)

Very Often
(5)

Always (6)

Has feeling
bored made
you worry
or agonize
about your
shape? (1)

o

o

o

o

o

o

Have you
thought that
your thighs,
hips or
bottom are
too large for
the rest of
you? (2)

o

o

o

o

o

o

Have you
felt so bad
about your
shape that
you have
cried? (3)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Have you
avoided
running
because
your flesh
might
wobble? (4)
Has being
with thin
people made
you feel
selfconscious
about your
shape? (5)
Have you
worried
about your
thighs
spreading
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out when
sitting
down? (6)
Has eating
sweets,
cakes, or
other high
calorie food
made you
feel fat? (7)

o

o

o

o

o

o

Has worry
about your
shape made
you feel you
ought to
exercise?
(8)

o

o

o

o

o

o

Q78 During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting,
digging, aerobics, or fast bicycling?
▼ 0 (1) ... 7 (8)

Q80 How much time did you usually spend doing vigorous physical activities on one of those
days?

o Hours per day (1) ________________________________________________
o Minutes per day (2) ________________________________________________
Q82 During the last 7 days, on how many days did you do moderate physical activities like
carrying light loads, bicycling at a regular pace, or doubles tennis? Do not include walking.
▼ 0 (1) ... 7 (8)

Q84 How much time did you usually spend doing moderate physical activities on one of those
days?

o Hours per day (1) ________________________________________________
o Minutes per day (2) ________________________________________________
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Q86 During the last 7 days, on how many days did you walk for at least 10 minutes at a time?
▼ 0 (1) ... 7 (8)

Q88 How much time did you usually spend walking on one of those days?

o Hours per day (1) ________________________________________________
o Minutes per day (2) ________________________________________________
Q90 During the last 7 days, how much time did you spend sitting on a week day?

o Hours per day (1) ________________________________________________
o Minutes per day (2) ______________________________________________
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Appendix F
IRB Approval Letter
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